F2RL1 and atopic eczema: Indeed, in patients with atopic dermatitis, PAR1 and PAR2 were activated in skin keratinocytes, with subsequent triggering of NFκB pathway and release of IL-8, IL-6, and granulocyte macrophage colony-stimulating factor (GM-CSF) (60, 61).